Merck
Top Ten most popular articles on Pharmafile.com this week
August 11, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, Merck, NICE, Parkinson's, biotech, diabetes, pharma, pharmaceutical, top ten
Another week, another busy week in pharma. The last seven days have seen some remarkable strides in the diabetes space, …
Merck scores expanded NICE recommendation in head, neck and oral cancer
August 8, 2017Manufacturing and Production, Sales and Marketing Erbitux, Merck, NICE, biotech, cetuximah, drugs, life sciences, pharma, pharmaceuticals
Merck has announced its approval of NICE’s decision to expand its recommendation of Erbitux (cetuximab) to include its use as …
AZ attempts to clear dust of Mystic trial with $8.5 billion MSD deal
July 27, 2017Medical Communications, Sales and Marketing AstraZeneca, MSD, Merck, biotech, drugs, immunotherapy, mystic, pharma, pharmaceutical
It will be some time before the Mystic catastrophe hoo-ha dies down for AstraZeneca but it made a pre-emptive move …
MSD’s Keytruda hits rare snag, floundering in confirmatory trial
July 25, 2017Manufacturing and Production, Sales and Marketing MSD, Merck, biotech, drugs, keytruda, pharma, pharmaceutical
Since the PD-1/PD-L1 immunotherapies have hit the market, they have revolutionised cancer care for many patients yet, with the science …
Merck to lay off 200 as part of 5-year reorganisation plan
July 18, 2017Manufacturing and Production Merck, biotech, drugs, healthcare, pharma, pharmaceutical
German drug manufacturer Merck has announced its intention to streamline its manufacturing processes across Europe as part of a five-year …
Merck’s Allergopharma opens €42m biopharmaceutical plant
March 7, 2017Manufacturing and Production Allergopharma, Merck
Allergopharma, a subsidiary of Germany’s Merck, has completed construction on its new €42 million biopharmaceutical facility and declared it open …
Merck eyes new India bio-production facility
February 21, 2017Manufacturing and Production Merck
German pharmaceutical firm Merck has made it known that it has plans to expand its operations in India with a …
MSD’s Alzheimer’s drug failure undermines potential treatment pathway
February 15, 2017Research and Development Alzheimer's, MSD, Merck
MSD, known as Merck in North America, has announced that it has been forced to cancel a Phase 2/3 trial …
MSD’s drug given European approval for first-line treatment in NSCLC
February 1, 2017Sales and Marketing European Commission, MSD, Merck
The good news keeps coming for MSD, known as Merck in North America, and Keytruda, with a further label expansion …
MSD puts best foot forward in drug pricing debate
January 30, 2017Medical Communications, Sales and Marketing Drug pricing, MSD, Merck
MSD, known as Merck in North America, has taken a pre-emptive step in the drug pricing debate by releasing its …
BMS receives $625 million patent settlement boost from Merck
January 23, 2017Sales and Marketing BMS, MSD, Merck, keytruda, opdivo
Bristol-Myers Squibb were in desperate need of releasing good news after the brief announcement that it would no longer be …
22 pharma companies join forces for global non-communicable disease initiative
January 18, 2017Research and Development BMS, Celgene, Eisai, Eli Lilly, GSK, J&J, JJ, MSD, Merck, Novartis, Pfizer, Roche, Sanofi, Takeda
The World Economic Forum Annual Meeting in Switzerland has seen the launch of Access Accelerated, a global initiative consisting of …
Merck forges data analytics partnership with Palantir
January 17, 2017Manufacturing and Production, Research and Development, Sales and Marketing Merck, Palantir
Merck has teamed up with software and data-mining firm Palantir with the intention to utilise its data analytics services to …
Merck and Roche extend distribution ties
December 5, 2016Manufacturing and Production Merck, Roche, distribution
Merck KGaA and Roche have announced that they will further increase the distribution links between the two companies by having …
MSD’s Keytruda early success ends trial early
October 24, 2016Sales and Marketing MSD, Merck, Roche, keytruda, opdivo, tecentriq
MSD, known as Merck in the US, ended their Phase III trial of Keytruda for treatment of advanced urothelial cancer …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
